To prospectively investigate changes in M.D. Anderson Dysphagia Inventory (MDADI) scores in patients affected by naso- and oropharynx cancer after definitive radiochemotherapy (ChemoRT) using swallowing organs at risk (SWOARs)-sparing IMRT.
Patient-reported outcomes after swallowing (SWOARs)-sparing IMRT in head and neck cancers: primary results from a prospective study endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) / Ursino, S., Calistri, E., De Felice, F., Bonomo, P., Desideri, I., Franco, P., Arcadipane, F., Colosimo, C., Mazzola, R., Maddalo, M., Gonnelli, A., Malfatti, G., Morganti, R., Musio, D., Paiar, F.. - In: DYSPHAGIA. - ISSN 0179-051X. - (2022). [10.1007/s00455-022-10434-4]
Patient-reported outcomes after swallowing (SWOARs)-sparing IMRT in head and neck cancers: primary results from a prospective study endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
De Felice, Francesca;
2022
Abstract
To prospectively investigate changes in M.D. Anderson Dysphagia Inventory (MDADI) scores in patients affected by naso- and oropharynx cancer after definitive radiochemotherapy (ChemoRT) using swallowing organs at risk (SWOARs)-sparing IMRT.| File | Dimensione | Formato | |
|---|---|---|---|
|
Ursino_Patient‑Reported_2022.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
977.26 kB
Formato
Adobe PDF
|
977.26 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
